泰格医药

- 300347

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
泰格医药(300347) 利润表
单位:万元
报表日期2025-03-312024-12-312024-09-302024-06-302024-03-31
一、营业总收入156,414.36660,312.02506,761.54335,824.42166,020.43
营业收入156,414.36660,312.02506,761.54335,824.42166,020.43
二、营业总成本142,141.80561,004.80402,655.05262,626.98130,528.78
营业成本109,438.27436,110.69309,733.34202,519.66103,208.07
营业税金及附加702.812,803.822,238.561,449.39770.05
销售费用4,869.5920,760.7814,493.5310,137.794,645.23
管理费用18,048.7173,684.2555,842.6337,661.5917,706.85
财务费用3,174.843,806.703,137.11-1,610.87-2,192.04
研发费用5,907.5823,838.5517,209.8812,469.426,390.62
资产减值损失----------
公允价值变动收益-2,239.18-50,168.82-3,441.19-9,840.311,275.33
投资收益2,530.9716,664.2210,915.827,074.35-359.12
其中:对联营企业和合营企业的投资收益--3,127.09--4,409.51--
汇兑收益----------
三、营业利润14,450.4466,441.90108,499.5968,706.9436,219.62
加:营业外收入15.95509.01533.72495.0430.12
减:营业外支出103.86504.76326.81192.6713.33
其中:非流动资产处置损失----------
四、利润总额14,362.5366,446.15108,706.5069,009.3236,236.42
减:所得税费用3,364.4521,663.0218,392.9513,251.454,979.38
五、净利润10,998.0844,783.1390,313.5555,757.8731,257.04
归属于母公司所有者的净利润16,546.8740,514.3581,342.8949,284.8923,507.20
少数股东损益-5,548.794,268.788,970.666,472.987,749.84
六、每股收益
基本每股收益(元/股)0.19000.47000.94000.57000.2700
稀释每股收益(元/股)0.19000.47000.94000.57000.2700
七、其他综合收益532.98-3,036.75-5,070.99-3,037.09-2,223.92
八、综合收益总额11,531.0641,746.3885,242.5652,720.7829,033.12
归属于母公司所有者的综合收益总额17,140.8040,070.4978,727.1748,052.8822,750.21
归属于少数股东的综合收益总额-5,609.741,675.896,515.394,667.906,282.90
下载全部历史数据到excel中 返回页顶